1Campos VE,Maia A,Muccioli C,et al.Pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide-case reports.Arq Bras Oftalmol,2005,68(2):251
2Weller M,Wiedemann P,Heimann K.Proliferative vitreoretinopathyis it anything more than wound healing at the wrong place? Int Ophthalmol,1990,14(2):105
3Jonas JB.Intraocular availability of triamcinolone acetonide after intravitreal injection.Am J Ophthalmol,2004,137 (3):560
4Ip MS,Kumar KS.Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.Arch Ophthalmol,2002,120(9):1 217
5Kivilcim M,Peyman GA,El-Dessouky ES,et al.Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.Ophthalmic Surg Lasers,2000,31 (6):474
5Dash A K, Cudworth G C 2nd. Therapeutic applications of implantable drug delivery systems [J]. J Pharmacol Toxicol Methods, 1998, 40 (1) : 1 -12.
6Kunou N, Ogura Y, Hashizoe M, et al. Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits [ J ]. J Control Release, 1995, 37(1): 143-150.
